Dr. Pinney investigates the molecular mechanisms that link an adverse intrauterine milieu to the development of diabetes and obesity later in life. Specifically, she is researching how intrauterine growth restriction, gestational diabetes and in utero exposure to environmental toxicants contribute to the development of diabetes and obesity in offspring.
Scientists at Children’s Hospital of Philadelphia (CHOP) report that a drug candidate that blocks abnormal protein signals may lead to the first pharmacologic treatment for hereditary multiple exostoses (HME), a rare pediatric genetic disease.
Every day, we learn about the exciting new ways our investigators and staff at Children's Hospital of Philadelphia modernize medicine and revolutionize healthcare for children. This week, we're thrilled to report on a handful of new headlines about those breakthroughs, including a data-driven collaboration led by CHOP that aims to uncover the ties between cancer and birth defects through cloud-sharing
The shiny picture of the American dream sometimes belies underlying struggles. This may be especially true in suburban communities, where demographic shifts in the last decade have left growing numbers of families experiencing poverty or near-poverty conditions in which they struggle to pay the bills. And that has serious implications for children's health.